These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37792670)

  • 1. Postoperative Bleeding Complications Associated With Novel Oral Anticoagulants in Mohs Micrographic Surgery.
    Fahmy LM; Dowd ML; Loesch E; Denson EM; Pisano CE; Samie FH
    Dermatol Surg; 2024 Jan; 50(1):1-4. PubMed ID: 37792670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
    Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
    JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Assessment of Postoperative Bleeding Complications in Anticoagulated Patients Following Mohs Micrographic Surgery.
    Eilers RE; Goldenberg A; Cowan NL; Basu P; Brian Jiang SI
    Dermatol Surg; 2018 Apr; 44(4):504-511. PubMed ID: 29140870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs.
    Wang CL; Wu VC; Chang KH; Tu HT; Kuo CF; Huang YT; Chu PH; Kuo CC; Chang SH
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):147-154. PubMed ID: 31384926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unanswered questions and research priorities to optimise stroke prevention in atrial fibrillation with the new oral anticoagulants.
    Hankey GJ
    Thromb Haemost; 2014 May; 111(5):808-16. PubMed ID: 24285341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study.
    Gieling EM; van den Ham HA; van Onzenoort H; Bos J; Kramers C; de Boer A; de Vries F; Burden AM
    Br J Clin Pharmacol; 2017 Aug; 83(8):1844-1859. PubMed ID: 28205318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse events associated with mohs micrographic surgery: multicenter prospective cohort study of 20,821 cases at 23 centers.
    Alam M; Ibrahim O; Nodzenski M; Strasswimmer JM; Jiang SI; Cohen JL; Albano BJ; Batra P; Behshad R; Benedetto AV; Chan CS; Chilukuri S; Crocker C; Crystal HW; Dhir A; Faulconer VA; Goldberg LH; Goodman C; Greenbaum SS; Hale EK; Hanke CW; Hruza GJ; Jacobson L; Jones J; Kimyai-Asadi A; Kouba D; Lahti J; Macias K; Miller SJ; Monk E; Nguyen TH; Oganesyan G; Pennie M; Pontius K; Posten W; Reichel JL; Rohrer TE; Rooney JA; Tran HT; Poon E; Bolotin D; Dubina M; Pace N; Kim N; Disphanurat W; Kathawalla U; Kakar R; West DP; Veledar E; Yoo S
    JAMA Dermatol; 2013 Dec; 149(12):1378-85. PubMed ID: 24080866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications.
    Cheung JJC; Liu S; Li KKW
    Int Ophthalmol; 2019 Mar; 39(3):623-630. PubMed ID: 29435797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the effects of omitting aspirin in combined antithrombotic therapies for atrial fibrillation and acute coronary syndromes or percutaneous coronary interventions: meta-analysis of pooled data from the PIONEER AF-PCI, RE-DUAL PCI, and AUGUSTUS trials.
    Potpara TS; Mujovic N; Proietti M; Dagres N; Hindricks G; Collet JP; Valgimigli M; Heidbuchel H; Lip GYH
    Europace; 2020 Jan; 22(1):33-46. PubMed ID: 31603196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of novel oral anticoagulants in catheter ablation of atrial fibrillation.
    Hansen PS; Sanchez R; Walfridsson H
    Dan Med J; 2016 Feb; 63(2):. PubMed ID: 26836793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minor bleeding in patients with atrial fibrillation using a non-vitamin-K antagonist oral anticoagulant.
    Mitrovic D; Folkeringa R; Veeger N; van Roon E
    Curr Med Res Opin; 2020 Oct; 36(10):1571-1576. PubMed ID: 32573287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection, management, and outcome of vitamin K antagonist-treated patients with atrial fibrillation not switched to novel oral anticoagulants. Results from the Dresden NOAC registry.
    Michalski F; Tittl L; Werth S; Hänsel U; Pannach S; Sahin K; Weiss N; Beyer-Westendorf J
    Thromb Haemost; 2015 Nov; 114(5):1076-84. PubMed ID: 25994496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
    Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH
    Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and consequences of resuming oral anticoagulant therapy following hematuria and risks of ischemic stroke and major bleeding in patients with atrial fibrillation.
    Wang CL; Wu VC; Huang YT; Chen YL; Chu PH; Kuo CF; Wen MS; Chang SH
    J Thromb Thrombolysis; 2021 Jan; 51(1):58-66. PubMed ID: 32409936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding risk in patients with atrial fibrillation treated with combined anti-platelet and non-vitamin K antagonist oral anticoagulant therapy.
    Shin DG; Kim S; Kim YR
    Rev Cardiovasc Med; 2022 Jan; 23(1):2. PubMed ID: 35092194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation.
    Hellfritzsch M; Grove EL; Husted SE; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
    Europace; 2017 Jul; 19(7):1091-1095. PubMed ID: 28641379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
    Caprio FZ; Bernstein RA; Alberts MJ; Curran Y; Bergman D; Korutz AW; Syed F; Ansari SA; Prabhakaran S
    Cerebrovasc Dis; 2014; 38(4):247-53. PubMed ID: 25401389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics And Health Care Resources In Patients Treated With Oral Anticoagulants: Evidences From Italian Administrative Databases.
    Degli Esposti L; Andretta M; Di Pasquale G; Gambera M; Saragoni S; Perrone V; Buda S
    Vasc Health Risk Manag; 2019; 15():429-437. PubMed ID: 31632047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of cutaneous surgery in patients taking clopidogrel-containing anticoagulation.
    Cook-Norris RH; Michaels JD; Weaver AL; Phillips PK; Brewer JD; Roenigk RK; Otley CC
    J Am Acad Dermatol; 2011 Sep; 65(3):584-591. PubMed ID: 21514003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.